Current Editions
Biotech venture 1Q24: less activity but bigger round sizes
Disclosed venture financings sunk to their lowest number in six years, but larger round sizes kept the total raised stable
Data Byte
Discovery & Translation
Triple-negative breast cancer attracts target innovation at AACR
BioCentury identifies 44 new targets presented at meeting
Science spotlight: New immune evasion pathway, plus BBB breakdown mechanism and more
BioCentury’s roundup of translational innovations
Finance
Public equity report: Depression data drive Intra-Cellular’s $500M raise
Plus public offerings for Biohaven and TScan, and PIPEs for Cullinan and Zura
Management Tracks
Doug Williams leaving Sana
Plus: Baptista joins SmartCella and updates from LifeArc and Gain
BioCentury ISSN 1097-7201